Chronic Paroxetine Treatment Does Not Affect Sexual Behavior in Hormonally Sub-primed Female Rats Despite 5-HT1A Receptor Desensitization

Journal of Sexual Medicine

Volumn 8, Issue 4, 2011, Pages 976-988

  Snoeren, Eelke M S ^a   Refsgaard, Louise K ^a   Waldinger, Marcel D ^a,b   Olivier, Berend ^a,c   Oosting, Ronald S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b LEYENBURG HOSPITAL   (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Female Sexual Behavior; Paroxetine; Rat; SSRI

Indexed keywords

PAROXETINE; SEROTONIN 1A RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LONG TERM CARE; MATING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEXUAL BEHAVIOR;

EID: 79953305090     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02192.x     Document Type: Article

References (65)

1. Bancroft J, Loftus J, Long JS. Distress about sex: A national survey of women in heterosexual relationships. Arch Sex Behav 2003;32:193-208.
2. Dunn KM, Croft PR, Hackett GI. Sexual problems: A study of the prevalence and need for health care in the general population. Fam Pract 1998;15:519-24.
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition-TR. Am Psychiatr Assoc 2000:493-522.
5. Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in "normal" couples. N Engl J Med 1978;299:111-5.
6. Brotto LA, Bitzer J, Laan E, Leiblum S, Luria M. Women's sexual desire and arousal disorders. J Sex Med 2010;7:586-614.
7. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63:357-66.
8. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001;62(3 suppl):10-21.
9. Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: A descriptive clinical study of 33 patients. Int J Psychiatry Med 1995;25:239-48.
10. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999;19:67-85.
11. Segraves RT. Sexual dysfunction associated with antidepressant therapy. Urol Clin North Am 2007;34:575-9, vii.
12. Casper RC, Redmond DE Jr, Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Arch Gen Psychiatry 1985;42:1098-104.
13. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 1998;13(6 suppl):S1-4.
14. Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: A review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002;69:119-40.
15. Agmo A, Ellingsen E. Relevance of non-human animal studies to the understanding of human sexuality. Scand J Psychol 2003;44:293-301.
16. Matuszczyk JV, Larsson K, Eriksson E. Subchronic administration of fluoxetine impairs estrous behavior in intact female rats. Neuropsychopharmacology 1998;19:492-8.
17. Sarkar J, Hiegel C, Ginis GE, Hilbun E, Uphouse L. Subchronic treatment with fluoxetine attenuates effects of acute fluoxetine on female rat sexual behavior. Brain Res 2008;1190:56-64.
18. 1A receptor desensitization. J Sex Med 2010;7:2424-34.
19. Snoeren EM, Chan JS, de Jong TR, Waldinger MD, Olivier B, Oosting RS. A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence. J Sex Med 2010 Aug 30 [Epub ahead of print] doi: 10.1111/j.1743-6109.2010.01998.x.
20. 1A receptors: Differential involvement in female and male sexual behavior in the rat. Physiol Behav 1986;37:345-51.
21. 1A receptor agonists on lordosis in female rats. Zoolog Sci 2003;20:1133-8.
22. 1A receptors in the mediation of lordosis behavior in the female rat. Psychopharmacology (Berl) 1989;98:440-4.
23. 1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol 1998;125:1733-43.
24. 1A receptors. J Pharmacol Exp Ther 1997;282:1581-90.
25. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 1995;352:141-8.
26. Heisler LK, Kanarek RB, Homoleski B. Reduction of fat and protein intakes but not carbohydrate intake following acute and chronic fluoxetine in female rats. Pharmacol Biochem Behav 1999;63:377-85.
27. 1A) receptors with no change in 5-HT(2A) receptors. Neuropharmacology 2002;43:45-54.
28. Uphouse L, Hensler JG, Sarkar J, Grossie B. Fluoxetine disrupts food intake and estrous cyclicity in Fischer female rats. Brain Res 2006;1072:79-90.
29. Sarkar J, Hiegel C, Maswood N, Uphouse L. Daily male exposure attenuates estrous cycle disruption by fluoxetine. Behav Brain Res 2008;189:83-91.
30. Mendelson SD, Gorzalka BB. Sex differences in the effects of 1-(m-trifluoromethylphenyl) piperazine and 1-(m-chlorophenyl) piperazine on copulatory behavior in the rat. Neuropharmacology 1990;29:783-6.
31. Maswood N, Sarkar J, Uphouse L. Modest effects of repeated fluoxetine on estrous cyclicity and sexual behavior in Sprague Dawley female rats. Brain Res 2008;1245:52-60.
32. 1A receptor agonist, 8-OH-DPAT. Pharmacol Biochem Behav 2002;72:533-42.
33. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997;283:1305-22.
34. Gould GG, Altamirano AV, Javors MA, Frazer A. A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiatry 2006;59:408-14.
35. de Jong TR, Pattij T, Veening JG, Waldinger MD, Cools AR, Olivier B. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: Comparison of fluvoxamine and paroxetine. Psychopharmacology (Berl) 2005;179:509-15.
36. de Jong TR, Snaphaan LJ, Pattij T, Veening JG, Waldinger MD, Cools AR, Olivier B. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. Eur Neuropsychopharmacol 2006;16:39-48.
37. Chan JSW, Waldinger MD, Olivier B, Oosting RS. Drug induced sexual dysfunction in rats. Curr Protoc Neurosci 2010 Oct;Chapter 9:Unit 9.34.
38. Taylor GT, Farr S, Klinga K, Weiss J. Chronic fluoxetine suppresses circulating estrogen and the enhanced spatial learning of estrogen-treated ovariectomized rats. Psychoneuroendocrinology 2004;29:1241-9.
39. 1A) receptors in fluoxetine-induced lordosis inhibition. Horm Behav 2010;58:290-6.
40. White S, Uphouse L. Estrogen and progesterone dose-dependently reduce disruptive effects of restraint on lordosis behavior. Horm Behav 2004;45:201-8.
41. 1A agonist in the VMN. Brain Res 1994;637:173-80.
42. 1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior. Brain Res 2003;974:202-11.
43. Uphouse L. Female gonadal hormones, serotonin, and sexual receptivity. Brain Res Brain Res Rev 2000;33:242-57.
44. Kennedy SH, Ralevski E, Davis C, Neitzert C. The effects of moclobemide on sexual desire and function in healthy volunteers. Eur Neuropsychopharmacol 1996;6:177-81.
45. Nafziger AN, Bertino JS Jr, Goss-Bley AI, Kashuba AD, Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy. J Clin Psychiatry 1999;60:187-90.
46. Waldinger MD, Olivier B. Sexual dysfunction and fluvoxamine therapy. J Clin Psychiatry 2001;62:126-7.
47. 1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology (Berl) 1991;105:415-20.
48. 1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects. Clin Pharmacol Ther 1998;63:428-36.
49. 1A receptor function in normal subjects on clinical doses of fluoxetine: Blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology 1999;20:628-39.
50. 1A) receptor-mediated feedback: A microdialysis study in the amygdala. J Neurochem 2001;76:1645-53.
51. 1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport 1999;10:1441-5.
52. Uphouse L, Wolf A. WAY-100635 and female rat lordosis behavior. Brain Res 2004;1013:260-3.
53. 1A partial agonist/antagonist, NAN-190, on female sexual behavior. Neuropharmacology 1992;31:969-81.
54. 1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment. Eur Neuropsychopharmacol 2001;11:15-24.
55. 1A receptor function in brain following agonist or antidepressant administration. Life Sci 2003;72:1665-82.
56. 1A receptor antagonist. Behav Brain Res 1996;73:337-53.
57. 1A receptors. J Recept Signal Transduct Res 2002;22:483-95.
58. 1A agonist, 8-OH-DPAT, in male rats. Brain Res 1993;630:148-56.
59. 1A receptor regulation. Effect of 5, 7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 1991;4:131-44.
60. Siddiqui A, Niazi A, Shaharyar S, Wilson CA. The 5HT(7) receptor subtype is involved in the regulation of female sexual behaviour in the rat. Pharmacol Biochem Behav 2007;87:386-92.
61. Mendelson SD, Gorzalka BB. A facilitatory role for serotonin in the sexual behavior of the female rat. Pharmacol Biochem Behav 1985;22:1025-33.
62. Wolf A, Caldarola-Pastuszka M, Uphouse L. Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists. Brain Res 1998;779:84-95.
63. 1A) receptors. Psychopharmacology (Berl) 2002;164:392-400.
64. Beach FA, Orndoff RK. Variation in the responsiveness of female rats to ovarian hormones as a function of preceding hormonal deprivation. Horm Behav 1974;5:201-5.
65. 1A agonist, 8-OH-DPAT, on lordosis behavior. Horm Behav 1996;30:145-52.